In addition to genetic predispositions, variability in TC and TG concentration results from physical activity, diet, including carbohydrate and alcohol content, and smoking
By Nancy Lapid July 22 (Reuters) The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest
doi: 10.1053/j.gastro.2007.03.054 13 ZhaoXWangMWenZLuZCuiLFuCet al
L'ARA-290 (cibinetide) is an 11-amino-acid peptide that selectively activates the EPO-R/CD131 (innate repair receptor) complex without stimulating erythropoiesis or increasing hematocrit
Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B, et al
The experts will discuss how GLP-1 medications work, possible side effects, and who might be an ideal candidate for this type of therapy